Abstract
Introduction

Atorvastatin belongs to a class of drugs known as statins, and is mainly used to lower serum cholesterol level by inhibiting the conversion of 3-hydroxy-3-methylglutaryl-coenzyme A (HMGCoA) to mevalonate by HMG-CoA reductase, a rate-limiting step in the cholesterol biosynthesis pathway. However, this also prevents the synthesis of downstream products such as farnesyl pyrophosphate and geranylgeranyl pyrophosphate (GGPP), which are needed for post-translational activation (prenylation) of small GTPases such as Ras and Rho. Failure in the prenylation of these GTPases results in their inability to interact with a wide spectrum of functionally different downstream mediators to initiate cytoplasmic signalling pathways and to regulate cell cycle progression [1]. Hence, statins have a pleiotropic effect of inhibiting growth of a number of cancer cells, but their mechanism of action is still not well established [2]. The problem lies in the diversities of lipophilicity of statins and cell types used in the studies. A number of statins have been shown to induce cell growth arrest and apoptosis of prostate and breast cancer cells in in vitro as well as in vivo studies
. The prevention of prenylation of the small GTPase RhoA has been implicated for the action of statin [9] . However, the downstream mediators have not been well characterized. A number of candidates have been reported, these include p21 [10] , E2F transcription factor 1 (E2F-1) [11] , caspase-7 [12] , caspases-3 and -9 [13] , insulin-like growth factor 1 receptor [14] and inducible nitric oxide synthase [15] . Besides statin-induced apoptosis, simvastatin-(at higher dose, 60 M) induced necrosis mediated by calcineurin and mitochondrial dysfunction [16] . More recently, atorvastatin has been shown to induce cell death in PC-3 cells via autophagy [17] .
In 
Construction of reporter plasmids
RT-PCR
Luciferase reporter assay
Luciferase reporter assays were carried out as described in our earlier study [25] . (Fig. 2) (Fig. 3) . [26, 27] (Fig. 4) , similar to the results reported by other investigators using cerivastatin and other cancer cell lines [28, 29] . On the other hand, ZnPP did not protect the cells from atorvastatin-induced cell death (Fig. 4) . For the regulation of HO-1 expression, no significant decrease of atorvastatin-induced HO-1 mRNA in the presence of GGPP was observed (Fig. 5, as compared to Fig. 2) . Surprisingly, ZnPP was a stronger inducer of HO-1 than atorvastatin, and synergistic effect with atorvastatin could be seen in MCF-7 cells (Fig. 5) Figure 6 , StRE3 showed the highest induction level by atorvastatin, although these elements had different levels of relative luciferase activities due to different copy number of the response elements present in the luciferasereporter constructs. Besides these StRE sites, other response elements, such as HSE [22] , SREBP [23] and SP1 [24] sites have also been reported to be present in HO-1 promoter. Atorvastatin did not activate the HSE, SREBP and SP1 elements (Fig. 6 ). [30] , macrophage [31] , neuronal cells [32] , liver [33] , cultured human dental pulp cells [34] and vascular smooth muscle cells [35] . To [33] and vascular smooth muscle cells by fluvastatin [37] . Interaction of Nrf2 and Bach1, two proteins of opposing action, with the StRE of human HO-1 promoter has also been reported [38] [31] . It was recently reported that HO-1 was up-regulated through mRNA stabilization [39] .
Measurement of cell survival
Results
Atorvastatin induced significant cell death in PC-3 cells at a concentration of 1 M (data not shown
. There was also a slight increase in the expression of NQO1 and GXP2 in MCF-7 cells. The failure in detecting an increase of expression of these genes in PC-3 cells may be due to their relatively high basal expression. Minor bands of lower molecular weight HO-1 and higher molecular weight of UGT were also observed in Figure 2, these may represent unspecific PCR products or alternatively spliced mRNA. Induction of HO-1 by atorvastatin in both PC-3 and MCF-7 cells was confirmed by Western blot analysis
Fig. 1 Effect of atorvastatin on activities of ARE, HSE, FOXO and E2F1 elements in PC-3 cells. PC-3 cells were transfected with enhancer-luciferase reporter plasmid harbouring ARE site of human NQO1 promoter, potential HSE/NF-B binding site of p53 promoter, FOXO site of rat Bim promoter or E2F-1 consensus binding site and pGL4.74 [hRluc/TK] internal control plasmid, treated with 10 M atorvastatin for 48 hrs and luciferase activities were determined as described in 'Materials and methods'. Results were expressed as relative luciferase activity (mean Ϯ S.D.).
Fig. 2 Effect of atorvastatin on expression of various genes in PC-3 and MCF-7 cells. (Top) Total RNA was isolated from PC-3 cells treated with 10 M atorvastatin or equal amount of DMSO (vehicle control) for 48 hrs, and expression of ␤-actin, NQO1, Nrf2, HO-1, GPX2, GSTM1 and UGT1A1 was analysed by RT-PCR using gene-specific primers. The PCR products were analysed on 2% agarose gel in pairs (left lane, control; right lane, atorvastatin-treated). (Bottom) Similar analysis by RT-PCR using RNA isolated from MCF-7 cells treated with 50 M atorvastain or vehicle for 48 hrs.
Fig. 3 Western blot analysis of HO-1 protein induced by atorvastatin in PC-3 and MCF-7 cells. PC-3 and MCF-7 cells were treated with 10 and 50 M atorvastatin, respectively, for 48 hrs. Total proteins (100 g) were analysed by Western blot as described in 'Materials and methods'. Samples are: (1) MCF-7 vehicle control, (2) MCF-7 treated with atorvastatin, (3) PC-3 vehicle control and (4) PC-3 treated with atorvastatin. Immunoreactive protein bands detected by WesternDot 625 appeared as fluorescent bands.
Basal expression of HO-1 in PC-3 and MCF-7 cells was low, and overexpression of HO-1 in these cells was shown to inhibit cell proliferation and invasion
. Therefore, it is likely that HO-1 is the mediator of atorvastatin-induced cell death in these cells. To investigate the role of HO-1 in atorvastatin-induced cell death, the effect of GGPP (an intermediate in the HMG-CoA reductase pathway) and ZnPP (an inhibitor of HO-1) on induction of cell death and regulation of HO-1 expression by atorvastatin was examined. When PC-3 cells were pre-incubated with GGPP, atorvastatin-induced cell death was abrogated
Discussion
In this study, we demonstrated that atorvastatin up-regulated HO-1 expression in PC-3 and MCF-7 cells and that up-regulation was done through activation of the
The has been shown to inhibit proliferation of some hormone-refractory prostate cancer cells [41] . On the other hand, anti-proliferative and pro-apoptotic functions of HO-1 have been reported in prostate cancer [26] , breast cancer [27] and oral cancer [42] [44] .
In summary, atorvastatin was found to induce apoptosis and up-regulation of HO-1 in PC-3 and MCF-7 cells. However, the role of HO-1 in atorvastatin-induced apoptosis in these cells remains to be studied.
